A group of prominent physicians and researchers have called upon professional medical groups to progressively sever all links with the drug industry.
In a statement Wednesday, they suggested stricter conflict-of-interest guidelines for medical professional associations.
Iin the April 1 issue of The Journal of the American Medical Association, the group stressed that mere disclosure of financial ties to drug and medical device companies would not do. Members with financial ties should be excluded from leadership positions within the association.
Besides, over a period of time there should be complete ban sponsorships of committees that develop clinically important guidelines and training programs.
And out goes by the window even souvenir pens and tote bags funded by the corporates.
The authors acknowledged that while it would be difficult, even painful, to carry out the reforms, they were essential if physician associations are to maintain their scientific integrity and the trust of their patients.
When we write a practice guideline, we are telling our colleagues how they should care for their patients, said Dr. Steven E. Nissen, one of the authors of the paper and a past president of the American College of Cardiology, who supports what he calls a zero dollar policy, under which medical associations would not take any money from industry. If you are one of those patients, you are counting on that guideline to be of the highest caliber, free of any influence.